The burden of COPD in the UK: results from the Confronting COPD survey
The burden of COPD in the UK: results from the Confronting COPD survey
复制标题
DOI：
10.1016/s0954-6111(03)80027-6
复制
发表时间：
2003-03-01
影响因子：
4.3
通讯作者：
Britton, M
中科院分区：
文献类型：
--
作者：
Britton, M
慢性阻塞性肺疾病（COPD）是一种以进行性气流受限和肺功能下降为特征的疾病。与世界上其他发达国家一样，在英国，COPD与相当高的死亡率相关，该病的发病率给医疗保健系统和社会带来了沉重的负担。尽管慢性阻塞性肺病在这个国家造成了明显的负担，但公众对慢性阻塞性肺病缺乏认识。卫生保健专业人员也可能未能认识到疾病的负担，如诊断不足和管理不足所示。提高对慢性阻塞性肺病负担的认识的一个关键步骤是获得有关该疾病对患者、卫生服务和社会影响的全面信息。这项名为“北美和欧洲面对慢性阻塞性肺病”的大型国际调查旨在通过采访八个国家的患者和医生来解决这一信息需求。对英国患者调查反应的经济分析显示，慢性阻塞性肺病给医疗保健系统和社会带来了沉重的负担，每位患者每年的直接成本估计为819.42英镑，间接成本为819.66英镑，导致每位患者的总成本为1639.08英镑。由于住院治疗，该病对二级保健的成本影响尤为明显，占直接费用的54%。这些结果表明，减少患者对医院护理的需求可以减轻慢性阻塞性肺病对英国医疗保健系统的负担。这将要求在初级保健方面大大改进卫生保健专业人员管理该病的方式，尽早诊断并采用旨在预防疾病恶化和延缓疾病进展的干预措施。2003爱思唯尔科学有限公司
Chronic obstructive pulmonary disease (COPD) is a condition characterized by progressive airflow limitation and decline in lung function, As seen in other developed countries throughout the world, COPD in the U.K. is associated with considerable mortality, and morbidity from the disease places a significant burden on the healthcare system and society. Despite the obvious burden of COPD in this country, there is a lack of recognition of COPD among the general public. Healthcare professionals may also fail to recognize the burden of disease, as shown by underdiagnosis and inadequate management.A key step in increasing awareness of the burden of COPD is obtaining comprehensive information about the impact of the disease on patients, the health service and society. The large-scale international survey, Confronting COPD in North America and Europe, aimed to address this need for information, by interviewing patients and physicians in eight countries. An economic analysis of patient responses to the survey in the U.K. showed that COPD places a high burden on the healthcare system and society, with annual direct costs estimated at 819.42 pounds per patient, and indirect cost at 819.66 pounds per patient, resulting in total per patient costs of 1639.08 pounds. The cost impact of the disease was particularly marked in secondary care, as a result of inpatient hospitalizations, amounting to 54% of direct costs. These results suggest that reducing patient requirement for hospital care could alleviate the burden of COPD on the U.K. healthcare system. This will require considerable improvements to the way the disease is managed by healthcare professionals in primary care, with earlier diagnosis and the use of interventions aimed at preventing exacerbations and delaying the progression of disease. (C) 2003 Elsevier Science Ltd.